Products
.jpg){kind=logo}
Latest Partnered Companies
Projects
Estimated Cost :
€440 Million
Merck Invests to Construct New Filtration Manufacturing Facility in Ireland
Merck plans to expand membrane and filtration manufacturing capabilities. The two new facilities will be located in Ireland.
Estimated Cost :
-
Synthego Plans to Open New 20,000-Square-Foot Manufacturing Facility in San Francisco, USA
Synthego plans to construct new Next-Generation Manufacturing Facility. The facility is designed
Estimated Cost :
$2.1 Billion
Lilly Plans to Invest $2.1 billion in New Manufacturing Sites in Indiana
Eli Lilly and Company plans to expand its manufacturing footprint in Indiana by investing $2.1 billion in two new manufacturing sites at Indiana's LEA...
Estimated Cost :
US$170 million
Hovione Invests US$170 million to Expand Global Capacity
Hovione plans to expand its new capacity and capabilities in Portugal, Ireland, and New Jersey with an investment of US$170 million. This expansion o...
Press Release
Ascletis Announces IND Filing of Oral 3CLpro Inhibitor ASC11 for COVID-19 Accepted by China NMPA
Ascletis Pharma Inc. announces today that the Investigational New Drug application of ASC11, an oral inhibitor drug candidate targeting 3-chymotrypsin like protease for COVID-19, has been accepted by China National Medical Products Administration.In antiviral cellular assays with infectious SARS-CoV-2, ASC11
Aptamer Group opens new state-of-the-art laboratories
Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, announces that it has opened its new facilities in York Science Park, UK, that will enable it to meet the increasing demand for Optimer technology. The eminent neuroscience researcher Baroness Susan Greenfield opened
Biocytogen Enters into Antibody Agreement with ADC Therapeutics
Biocytogen Pharmaceuticals Co., Ltd. today announced that it has entered into an evaluation and option agreement with ADC Therapeutics SA. Biocytogen will grant ADC Therapeutics a license to evaluate Biocytogen’s proprietary antibodies against three tumor targets, with an option to license selected antibodies
US Partial Clinical Hold on Diamyd® Phase III Trial Lifted by the FDA
Diamyd Medical announced today that the U.S. Food and Drug Administration has lifted the partial clinical hold on the confirmatory Phase III trial DIAGNODE-3, evaluating the safety and efficacy of the precision medicine and antigen-specific immunotherapy Diamyd® in individuals recently diagnosed with type 1
Events
Gastroenterology & Hepatology Conference
Athletic Training and Sports Medicine Conference
Articles
Top 12 Analytical Lab Equipments in Pharmaceutical Industry
The analytical lab equipments or instruments are used in analytical applications in pharmaceutical, food-processing laboratories
A Complete Guide on Blister Packaging Machine
Packaging machinery is one of the vital equipment in the pharmaceutical industry, food processing, and chemical
Nanotechnology in Drug Delivery to Eyes, Skin, and Wounds Via Topical Route
One of the most favored courses for administering medications to eyes, skin, and wounds is the topical route. The principle objective for this
An Overview - Active Pharmaceutical Ingredient (API)
Active Pharmaceutical Ingredient (API) is the term used to refer to the biologically active component of a drug product
Next-Generation Biological Therapeutics Discovery & Development
Focus on drug discovery and development has shifted away from small to large, complex molecular entities
Expert Talk
Testimonials
I have read it with interest. I think it could be of interest to managers and professionals in Asia's Pharma companies as well as global companies that wish to learn more about how to do business--from R&D to marketing-in Asia.
Baoping Wang - Research Director
Novo Nordisk (China) R&D Centre
Thank you for contacting us. One of our support staff will get in touch with you shortly.
Happy Surfing!
Regards,
Client Success Team (CRM),
